- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
- 10-Q Quarterly report
- 4.5 Form of Series 6 Preferred Stock Certificate
- 4.6 Form of Common Stock Purchase Warrant, Dated July 27, 2010
- 10.3 Form of Securities Purchase Agreement, Dated July 25, 2010
- 10.4 Form of Warrant Exchange Agreement, Dated July 25, 2010
- 10.5 Letter Agreement, Dated July 25, 2010
- 10.6 Drug Product Manufacturing Supply Agreement, Dated July 13, 2010
- 15 Letter Regarding Unaudited Interim Financial Information
- 31.1 Certification of Chief Executive Officer Pursuant to Section 302
- 31.2 Certification of Chief Financial Officer Pursuant to Section 302
- 32 Certification of CEO and CFO Pursuant to Section 906
Exhibit No. 15
August 6, 2010
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Commissioners:
We are aware that our report dated August 6, 2010 on our review of interim financial information of Cell Therapeutics, Inc. for the six month period ended June 30, 2010 included in the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2010 is incorporated by reference in the Registration Statements of Cell Therapeutics, Inc. on Forms S-3 (File Nos. 333-130411, 333-131533, 333-130004, 333-36038, 333-41300, 333-67906, 333-36603, 333-38431, 333-108926, 333-112681, 333-138170, 333-134126, 333-14352, 333-149980, 333-149981, 333-149982, 333-152170, 333-152171, 333-152172, 333-160969, 333-158272, 333-157376, and 333-153358) and on Form S-8 (File No. 333-65200, 333-58957, 333-35919, 333-97015, 333-106568, 333-106571, 333-112791, 333-118016, 333-146624, 333-152168, 333-158260 and 333-162955).
Yours very truly,
/s/ Stonefield Josephson, Inc.